AKT1 and neuroblastoma: Perifosine, an AKT inhibitor that also inhibits the ERK and JNK pathways [91,92], decreased neuroblastoma cell proliferation, decreased tumor growth, and increased survival in mice bearing neuroblastoma xenografts [93].